Immunotherapy in pediatric patients with respiratory allergy: ultra-rush induction scheme

被引：0
|
作者：
Luz, S. [1 ]
Geraldo Dias, J. [1 ]
Palma Carlos, S. [2 ]
Leiria Pinto, P. [2 ]
机构：
[1] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Immunoallergol Dept, Lisbon, Portugal
[2] Ctr Hosp Lisboa Cent, Hosp Dona Estefania, Immunoallergol Dept, Lisbon, Portugal
来源：
ALLERGY | 2011年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
508
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [31] Adverse reaction to sublingual Parietaria vaccine following an ultra-rush induction
    Scala, G.
    Ciccarelli, A.
    Calabro, C.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 46 (03) : 116 - 118
  • [32] REVIEW OF ULTRA-RUSH BEE VENOM IMMUNOTHERAPY IN CHILDREN AT FLINDERS MEDICAL CENTRE
    Mackey, Leigh
    Ziegler, Christine
    Smith, Anthony
    Johannsen, Henning
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 18 - 19
  • [33] A sting in time saves nine - venom ultra-rush immunotherapy, a patient perspective
    Hughes, Alex
    Dixon, John
    Mullan, Daniel
    Leeman, Lucy
    Whyte, Andrew
    Bethune, Claire
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (12): : 1661 - 1661
  • [34] Safety of a ultra-rush dose-increase protocol for hymenoptera venom immunotherapy
    Bucher, C
    Schwager, S
    Schmid-GRendelmeier, P
    Wuthrich, B
    ALLERGY, 2002, 57 : 76 - 76
  • [35] Time-dependent cytokines changes in ultra-rush wasp venom immunotherapy
    Urbanska, W.
    Szymanski, L.
    Ciepelak, M.
    Cios, A.
    Stankiewicz, W.
    Klimaszewska, E.
    Lieto, Krystyna
    Skopek, Rafal
    Chcialowski, A.
    Lewicki, S.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] Safety of allergen immunotherapy rush regimen in respiratory allergy
    Sacramento Monteiro, I
    Duarte, F.
    Mascarenhas, I
    Dias, J.
    Silva, S.
    Silva, S.
    Celia, C.
    Spinola Santos, A.
    Branco-Ferreira, M.
    Pedro, E.
    Barbosa, M.
    ALLERGY, 2010, 65 : 568 - 569
  • [37] Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
    Moura, A. L.
    Pereira, C.
    Regateiro, F. S.
    Azevedo, J.
    Bom, A. Todo
    Carrapatoso, I
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 51 (05) : 206 - 212
  • [38] Pru p 3 sublingual immunotherapy-rush protocol versus ultra-rush protocol: Comparing safety
    Silva, M., I
    Paulino, M.
    Duarte, F. C.
    Barbosa, M. P.
    Costa, C.
    ALLERGY, 2020, 75 : 133 - 133
  • [39] Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors
    Birnbaum, J
    Ramadour, M
    Magnan, A
    Vervloet, D
    CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (01): : 58 - 64
  • [40] Safety of ultra-rush protocol on venom immunotherapy: Evaluation of risk factors for adverse events
    Barradas Lopes, J.
    Santa, C.
    Ferreira, C.
    Mesquita, M.
    Barreira, P.
    Lopes, I
    ALLERGY, 2020, 75 : 101 - 102
12345